Atlas (Atlas Genetics Ltd) develops ultra-rapid decentralized and point-of-care (POC) diagnostic tests for infectious diseases. The Atlas io™ system uses patented technology based on the use of a novel electrochemical sensor that combines speed, accuracy and multiplex detection capability. The Company has its head office and laboratory facilities near Bath. Atlas was established in 2005 and is financed by VC, corporate and private investors including Novartis Venture Funds, Consort Medical plc, J&J Development Corporation, Life Science Partners (LSP), BB Biotech Ventures and YFM Equity Partners.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/29/14 | $28,400,000 | Series B |
BB Biotech Ventures Consort Medical Johnson & Johnson Innovation Novartis Venture Funds YFM Equity Partners | undisclosed |
